Biome Increases Australian Distribution

Open PDF
Stock Biome Australia Ltd (BIO.ASX)
Release Time 23 Jan 2025, 3:24 p.m.
Price Sensitive Yes
 Biome Increases Australian Distribution
Key Points
  • Biome expands its distribution in Australian practitioner and pharmacy markets to 6,000+ locations
  • 20% growth in distribution footprint from 5,000 (FY24) to 6,000+ locations over the last six months
  • Biome signs new deals with USF Dispensaries in Victoria and Greenleaf Pharmacies in WA
Full Summary

Microbiome health company Biome Australia Limited (ASX: BIO) is pleased to announce it has increased its total Australian distribution to over 6000 locations. Biome recently signed new distribution deals with USF Dispensaries in Victoria and Greenleaf Pharmacies in Western Australia. Biome's Activated ProbioticsĀ® product range is one of the highest growth brands in the Australian complementary medicine market, with data from Biome's two largest national retail pharmacy partners, Terry White Chemmart and Priceline Pharmacy, reporting 70% and 95% growth respectively over the 12 months to 31 December. Terry White has increased their national planogram of Activated Probiotics to three full shelves, and Priceline has increased their planogram to two full shelves. Biome's Activated Probiotics offers its customers new ways to drive growth in practitioner and pharmacy dispensaries, providing opportunities to increase profitability without cannibalising existing product offerings.

Outlook

The growth in distribution represents 33% of the new Australian distribution target in the Vision 27 Strategic plan of 8,000 locations before the close of FY27.